Quantum BioPharma Ltd.
QNTM
$3.02
-$0.34-9.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 43.54% | -38.98% | -197.35% | -350.60% | -284.39% |
| Total Depreciation and Amortization | 14.72% | 20.28% | 3.36% | 7.99% | -7.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 165.55% | 454.44% | 15,252.05% | 965.83% | -893.75% |
| Change in Net Operating Assets | -91.15% | 244.76% | -146.57% | 151.09% | 926.05% |
| Cash from Operations | 63.44% | 50.26% | -221.37% | -115.91% | 1.87% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -71.81% | 111.79% | -284.41% | -6,009.50% | -- |
| Cash from Investing | -71.81% | 111.79% | -284.41% | -6,009.50% | -- |
| Total Debt Issued | -98.90% | 189.70% | 12,245.28% | 984.32% | -- |
| Total Debt Repaid | -2,446.64% | -121.74% | -5,510.27% | -58.50% | -17.79% |
| Issuance of Common Stock | -77.25% | -100.00% | -92.09% | -84.51% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -42.68% | -96.12% | -30.09% | 450.99% | 9,891.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -49.25% | -464.16% | -202.24% | -73.65% | 427.93% |